11
TITLE: Current and potential biomarkers in gastric cancer: a critical review of the literature
AUTHORS: de Mello, RA; Amaral, GA; Neves, NM; Lippo, EG; Parini, F; Xu, S; Tolia, M; Charalampakis, N; Tadokoro, H; Castelo Branco, P; Zhu, JH;
PUBLISHED: 2021, SOURCE: FUTURE ONCOLOGY, VOLUME: 17, ISSUE: 25
INDEXED IN: WOS CrossRef: 11
IN MY: ORCID
12
TITLE: Dual role of allele-specific DNA hypermethylation within the TERT in cancer
AUTHORS: Lee, DD; Komosa, M; Sudhaman, S; Leao, R; Zhang, CH; Apolonio, JD; Hermanns, T; Wild, PJ; Klocker, H; Nassiri, F; Zadeh, G; Diplas, BH; Yan, H; Gallinger, S; Pugh, TJ; Ramaswamy, V; Taylor, MD; Castelo Branco, P; Nunes, NM; Tabori, U;
PUBLISHED: 2021, SOURCE: JOURNAL OF CLINICAL INVESTIGATION, VOLUME: 131, ISSUE: 21
INDEXED IN: Scopus WOS CrossRef: 13
IN MY: ORCID
13
TITLE: DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study
AUTHORS: Faleiro, I; Roberto, VP; Canli, SD; Fraunhoffer, NA; Iovanna, J; Gure, AO; Link, W; Castelo Branco, P;
PUBLISHED: 2021, SOURCE: CANCERS, VOLUME: 13, ISSUE: 24
INDEXED IN: WOS CrossRef: 4
IN MY: ORCID
14
TITLE: Screening for Colorectal Cancer Leading into a New Decade: The “Roaring ‘20s” for Epigenetic Biomarkers?  Full Text
AUTHORS: Hélder Almeida-Lousada; André Mestre; Sara Ramalhete; Aryeh J Price; Ramon Andrade de Mello; Ana D Marreiros; Ricardo Pires das Neves; Pedro Castelo-Branco;
PUBLISHED: 2021, SOURCE: Current Oncology, VOLUME: 28, ISSUE: 6
INDEXED IN: CrossRef: 7
IN MY: ORCID
15
TITLE: Marine Natural Products as a Promising Source of Therapeutic Compounds to Target Cancer Stem Cells
AUTHORS: Catarina Vizetto-Duarte; Pedro Castelo-Branco; Luísa Custódio;
PUBLISHED: 2021, SOURCE: Current Medicinal Chemistry, VOLUME: 28, ISSUE: 22
INDEXED IN: CrossRef: 10
IN MY: ORCID
16
TITLE: Albumin and CRP, Which is the Best Biomarker for Postoperative Complications on Colorectal Surgery? Prospective Cohort Study
AUTHORS: Miguel Fernandes Cunha; Beatriz Mendes; Pedro Mendanha; Ines Miguel; Juan Rachadell; Edgar Amorim; Pedro Castelo-Branco;
PUBLISHED: 2021
INDEXED IN: CrossRef
IN MY: ORCID
17
TITLE: Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness*
AUTHORS: Binnie, A; Walsh, CJ; Hu, PZ; Dwivedi, DJ; Fox Robichaud, A; Liaw, PC; Tsang, JLY; Batt, J; Carrasqueiro, G; Gupta, S; Marshall, JC; Castelo Branco, P; dos Santos, CC;
PUBLISHED: 2020, SOURCE: CRITICAL CARE MEDICINE, VOLUME: 48, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 37
IN MY: ORCID
18
TITLE: Epigenetics of Sepsis
AUTHORS: Binnie, A; Tsang, JLY; Hu, PZ; Carrasqueiro, G; Castelo Branco, P; dos Santos, CC;
PUBLISHED: 2020, SOURCE: CRITICAL CARE MEDICINE, VOLUME: 48, ISSUE: 5
INDEXED IN: WOS CrossRef: 44
IN MY: ORCID
19
TITLE: The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer
AUTHORS: Ramon Andrade De Mello; Nathalia Moises Neves; Giovanna Araujo Amaral; Estela Gudin Lippo; Pedro Castelo Branco; Daniel Humberto Pozza ; Carla Chizuru Tajima; Georgios Antoniou;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 9, ISSUE: 6
INDEXED IN: WOS CrossRef: 12
IN MY: ORCID
20
TITLE: Comparative cost-effectiveness analysis of avelumab plus axitinib versus pembrolizumab plus axitinib, ipilimumab plus nivolumab, and sunitnib for advanced renal cell carcinoma in the U.K. Perspective.
AUTHORS: Ramon Andrade De Mello; Emili Ayoub; Pedro Castelo-Branco; Victor Andre De Almeida Zia; Andre Savio; Daniel Humberto Pozza; Hakaru Tadokoro; Nelson Teich;
PUBLISHED: 2020, SOURCE: Journal of Clinical Oncology, VOLUME: 38, ISSUE: 6_suppl
INDEXED IN: CrossRef: 2
IN MY: ORCID
Page 2 of 5. Total results: 49.